Antiretroviral News and Research

RSS
Efforts underway in Namibia to treat pediatric HIV

Efforts underway in Namibia to treat pediatric HIV

Donors to reevaluate support for Myanmar's fight against HIV/AIDS

Donors to reevaluate support for Myanmar's fight against HIV/AIDS

Antiretroviral syrup for babies, mothers safely reduces HIV transmission

Antiretroviral syrup for babies, mothers safely reduces HIV transmission

Prevention, vaccines addressed at IAS conference

Prevention, vaccines addressed at IAS conference

IAS Conference begins, report says economic crisis forcing Africans living with HIV/AIDS off life-saving medications

IAS Conference begins, report says economic crisis forcing Africans living with HIV/AIDS off life-saving medications

GlaxoSmithKline pledges $97 million investment in AIDS drugs for Africa, allows South African drugmaker to produce generic second-line treatment

GlaxoSmithKline pledges $97 million investment in AIDS drugs for Africa, allows South African drugmaker to produce generic second-line treatment

Schering-Plough expands Vicriviroc study in treatment-naive patients with HIV

Schering-Plough expands Vicriviroc study in treatment-naive patients with HIV

Focusing HIV treatment helps control concurrent hepatitis B infection

Focusing HIV treatment helps control concurrent hepatitis B infection

Economic crisis already crippling global HIV/AIDS treatment, prevention programs, UNAIDS, World Bank report says

Economic crisis already crippling global HIV/AIDS treatment, prevention programs, UNAIDS, World Bank report says

IRIN examines government officials, advocates reaction to global fund restructuring in Zimbabwe

IRIN examines government officials, advocates reaction to global fund restructuring in Zimbabwe

IRIN examines PEPFAR funding of IDU programs

IRIN examines PEPFAR funding of IDU programs

Discovery on HIV replication may lead to new therapies

Discovery on HIV replication may lead to new therapies

PEPFAR and IDUs; economic crisis and health; human-rights and pharmaceutical companies

PEPFAR and IDUs; economic crisis and health; human-rights and pharmaceutical companies

Continued international investment, decreased discrimination key to fight against HIV/AIDS, says U.N. Secretary-General

Continued international investment, decreased discrimination key to fight against HIV/AIDS, says U.N. Secretary-General

GlaxoSmithKline to cut some drug costs in emerging markets

GlaxoSmithKline to cut some drug costs in emerging markets

Boston Globe examines the U.S. strategy towards global health

Boston Globe examines the U.S. strategy towards global health

Women, girls priority in U.S. efforts against global HIV/AIDS, Clinton tells international health experts

Women, girls priority in U.S. efforts against global HIV/AIDS, Clinton tells international health experts

Global AIDS coordinator nominee Goosby testifies before Senate committee

Global AIDS coordinator nominee Goosby testifies before Senate committee

Opinion: Second-line ARVs in India; PEPFAR funding

Opinion: Second-line ARVs in India; PEPFAR funding

Antiretroviral therapy earlier yields better clinical outcomes

Antiretroviral therapy earlier yields better clinical outcomes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.